Cargando…
The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway
BACKGROUND: Although tumor hypoxia poses challenges against conventional cancer treatments, it provides a therapeutic target for hypoxia-activated drugs. Here, we studied the effect of the hypoxia-activated synthetic quinoxaline di-N-oxide DCQ against breast cancer metastasis and identified the unde...
Autores principales: | Ghattass, Khaled, El-Sitt, Sally, Zibara, Kazem, Rayes, Saide, Haddadin, Makhluf J, El-Sabban, Marwan, Gali-Muhtasib, Hala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932516/ https://www.ncbi.nlm.nih.gov/pubmed/24461075 http://dx.doi.org/10.1186/1476-4598-13-12 |
Ejemplares similares
-
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
por: El-Khatib, Mona, et al.
Publicado: (2010) -
Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
por: Itani, Wafica, et al.
Publicado: (2007) -
Novel 2-(5-Imino-5H-isoquinolones[3,4-b]quinoxalin-7-ylmethyl)-benzonitrile
(DIQ3) and Other Related Derivatives Targeting Colon
Cancer Cells: Syntheses and in Vitro Models
por: Monzer, Alissar, et al.
Publicado: (2019) -
The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells
por: Haykal, Joelle, et al.
Publicado: (2009) -
Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)
por: EL-Hajjar, Layal, et al.
Publicado: (2018)